Press Releases
PHASTAR Launches Pro-Bono Scheme for Charities
PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data...
Press Releases
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces...
medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
Clinical testing...
Press Releases
BioAscent introduces the Compound Connect interface to connect drug...
BioAscent, the leading provider of integrated drug discovery services, has introduced a new web-based interface for customers using its compound management services. The Compound Connect...
Press Releases
Terumo Pharmaceutical Solutions expands CDMO services outside Japan for...
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has announced it will...
Press Releases
Silgan Dispensing Introduces Gemini BE Nasal Pump at CPHI...
To help pharmaceutical brands deliver faster-to-market nasal spray solutions, Silgan Dispensing, a global leader in the design, development and distribution of highly engineered pumps and...
Press Releases
IFF to Highlight Industry-Leading Product Portfolio, Expertise at CPhI...
IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based excipient...
Press Releases
Foundational partnership with Paradigm4 enables Alnylam Pharmaceuticals to rapidly...
Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.